Pharmaceutical companies face growing pressure to keep pharmacovigilance systems inspection-ready while managing outsourcing, quality gaps, and complex regulatory requirements. This article explains where external expertise adds value, how to evaluate support, and which controls matter most for sustainable compliance.
